Search hospitals > Louisiana > Baton Rouge
Ochsner Health Center-Summa
Claim this profileBaton Rouge, Louisiana 70809
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Skin Cancer
86 reported clinical trials
4 medical researchers
Summary
Ochsner Health Center-Summa is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Skin Cancer and other specialties. Ochsner Health Center-Summa is involved with conducting 86 clinical trials across 273 conditions. There are 4 research doctors associated with this hospital, such as Marc Matrana, MD, John Cole, MD, Burke J. Brooks, and Ryan P. Griffin.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Marc Matrana, MDOchsner Medical Center Jefferson4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
26 reported clinical trials
65 drugs studied
John Cole, MDOchsner Medical Center Jefferson7 years of reported clinical research
Studies Breast Cancer
Studies Cancer
11 reported clinical trials
40 drugs studied
Burke J. BrooksOchsner Health Center-Summa11 years of reported clinical research
Studies Colorectal Cancer
Studies Adenoma
1 reported clinical trial
2 drugs studied
Ryan P. GriffinMedical Center of Baton Rouge7 years of reported clinical research
Studies Adenocarcinoma
Studies Germ Cell Tumors
1 reported clinical trial
2 drugs studied
Clinical Trials running at Ochsner Health Center-Summa
Non-Small Cell Lung Cancer
Lung Cancer
Breast Cancer
Cancer
ALK Gene Rearrangement
Skin Cancer
Cutaneous Melanoma
Brain Metastasis
Tumors
Cardiotoxicity
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Osimertinib
for Non-Small Cell Lung Cancer
This phase II trial studies how well osimertinib works in treating patients with non-small cell lung cancer with EGFR exon 20 insertion mutation that is stage IIIB-IV or has come back (recurrent). Osimertinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 242 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ochsner Health Center-Summa?
Ochsner Health Center-Summa is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Skin Cancer and other specialties. Ochsner Health Center-Summa is involved with conducting 86 clinical trials across 273 conditions. There are 4 research doctors associated with this hospital, such as Marc Matrana, MD, John Cole, MD, Burke J. Brooks, and Ryan P. Griffin.